432 related articles for article (PubMed ID: 30468556)
1. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
Ullah K; Zubia E; Narayan M; Yang J; Xu G
FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.
Chen S; Yang J; Zhang Y; Duan C; Liu Q; Huang Z; Xu Y; Zhou L; Xu G
J Biol Chem; 2018 Jul; 293(29):11296-11309. PubMed ID: 29871923
[TBL] [Abstract][Full Text] [Related]
3. E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers.
Chang SC; Zhang BX; Ding JL
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188679. PubMed ID: 35074437
[TBL] [Abstract][Full Text] [Related]
4. Regulatory roles of an atypical ubiquitin ligase UBE2O in orphans of multiprotein complexes for degradation.
Lv Y; Xing F
Turk J Biol; 2022; 46(2):186-194. PubMed ID: 37533513
[TBL] [Abstract][Full Text] [Related]
5. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
6. A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy.
Vila IK; Yao Y; Kim G; Xia W; Kim H; Kim SJ; Park MK; Hwang JP; González-Billalabeitia E; Hung MC; Song SJ; Song MS
Cancer Cell; 2017 Feb; 31(2):208-224. PubMed ID: 28162974
[TBL] [Abstract][Full Text] [Related]
7. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
8. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
9. New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.
Hormaechea-Agulla D; Kim Y; Song MS; Song SJ
Mol Cells; 2018 Mar; 41(3):168-178. PubMed ID: 29562734
[TBL] [Abstract][Full Text] [Related]
10. RING E3-Catalyzed E2 Self-Ubiquitination Attenuates the Activity of Ube2E Ubiquitin-Conjugating Enzymes.
Banka PA; Behera AP; Sarkar S; Datta AB
J Mol Biol; 2015 Jul; 427(13):2290-304. PubMed ID: 25960396
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of generic versus specific E2-RING E3 interactions in protein ubiquitination.
Gundogdu M; Walden H
Protein Sci; 2019 Oct; 28(10):1758-1770. PubMed ID: 31340062
[TBL] [Abstract][Full Text] [Related]
12. Structural Diversity of Ubiquitin E3 Ligase.
Toma-Fukai S; Shimizu T
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771091
[TBL] [Abstract][Full Text] [Related]
13. Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.
Zhang X; Zhang J; Bauer A; Zhang L; Selinger DW; Lu CX; Ten Dijke P
EMBO J; 2013 Apr; 32(7):996-1007. PubMed ID: 23455153
[TBL] [Abstract][Full Text] [Related]
14. UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance.
Huang Y; Yang X; Lu Y; Zhao Y; Meng R; Zhang S; Dong X; Xu S; Wu G
Cell Death Differ; 2021 Feb; 28(2):671-684. PubMed ID: 32901121
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network.
Markson G; Kiel C; Hyde R; Brown S; Charalabous P; Bremm A; Semple J; Woodsmith J; Duley S; Salehi-Ashtiani K; Vidal M; Komander D; Serrano L; Lehner P; Sanderson CM
Genome Res; 2009 Oct; 19(10):1905-11. PubMed ID: 19549727
[TBL] [Abstract][Full Text] [Related]
17. Robust high-throughput assays to assess discrete steps in ubiquitination and related cascades.
Fenteany G; Gaur P; Sharma G; Pintér L; Kiss E; Haracska L
BMC Mol Cell Biol; 2020 Mar; 21(1):21. PubMed ID: 32228444
[TBL] [Abstract][Full Text] [Related]
18. E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2.
Anandapadamanaban M; Kyriakidis NC; Csizmók V; Wallenhammar A; Espinosa AC; Ahlner A; Round AR; Trewhella J; Moche M; Wahren-Herlenius M; Sunnerhagen M
J Biol Chem; 2019 Jul; 294(30):11404-11419. PubMed ID: 31160341
[TBL] [Abstract][Full Text] [Related]
19. Targeting E3 ubiquitin ligases for cancer therapy.
Sun Y
Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
[TBL] [Abstract][Full Text] [Related]
20. UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair.
Huang Q; Qin D; Pei D; Vermeulen M; Zhang X
FASEB J; 2022 Jan; 36(1):e22112. PubMed ID: 34921745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]